Articles, Explainers, Milestones

One bioreactor that handles both seed expansion and high-density production reduces facility capital, simplifies qualification, and compresses the seed train. Turndown ratio is the specification that makes it possible.

What if you could eliminate CIP systems, SIP piping, and cleaning validation from every stage of your seed train? Single-use seed trains do exactly that.

Scaling up used to mean starting over. With consistent geometry and mixing design, bench-to-commercial bioreactor translation is becoming predictable.

Explore engineered cellular models and screening approaches designed to support more targeted evaluation of adoptive cell therapies.

Explore the principles, technologies, and applications that enable scientists to design and build DNA for research, biotechnology, and therapeutic development.

Stainless steel is strong, but flexibility is faster. Single-use technology is rewriting the economics of biopharmaceutical facility design.

The hardest part of drug discovery isn't finding the molecule. It's making a million doses of it reliably, safely, and at commercial scale.

How automation can help ensure the safety and efficacy of advanced therapeutic products.

Refeyn’s MyMassMP enables fast protein analysis to support more confident structural and biophysical workflows.

Sensitive qPCR kits help researchers detect trace host-cell DNA contamination and support more reliable biologic quality control.

Before sequencers run, before spectrometers fire, before algorithms analyze — sample preparation has already determined how much of the truth you'll actually see

Learn how researchers isolated transient B cell populations to uncover a previously unrecognized mechanism of antibody maturation.